Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Cash flows from operating activities:
Net income (loss)	$ 670,839	$ 31,011
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	265,161	267,726
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions	(112,641)	(3,687)
Provision for current expected credit losses	11,562	(4,674)
Deferred taxes	4,301	35,797
Other, net	(7,092)	(18,495)
Changes in operating assets and liabilities, net of acquisitions:
Receivables	(591,106)	(100,398)
Inventories	(1,970,142)	(1,495,856)
Accounts payable and accrued expenses	511,223	273,448
Other liabilities	(85,646)	(119,417)
Net cash provided by (used in) operating activities	(1,303,541)	(1,134,545)
Cash flows from investing activities:
Acquisition of property, plant and equipment	(130,884)	(164,565)
Proceeds from disposition of property, plant and equipment	6,140	7,741
Expenditures for major repairs	(8,318)	(10,050)
Proceeds from Sales of Business, Affiliate and Productive Assets	55,546	39,567
Changes in CHS Capital notes receivable, net	(82,384)	43,283
Financing extended to customers	(30,474)	(1,816)
Payments from customer financing	33,310	5,589
Other investing activities, net	924	10,633
Net cash provided by (used in) investing activities	(156,140)	(69,618)
Cash flows from financing activities:
Proceeds from lines of credit and long-term borrowings	12,322,409	16,930,536
Payments on lines of credit, long-term borrowings and capital lease obligations	(11,008,138)	(15,483,358)
Preferred stock dividends paid	(84,334)	(84,334)
Redemptions of equities	(17,485)	(12,486)
Cash patronage dividends paid	(30,043)	(21,416)
Other financing activities, net	9,257	(9,222)
Net cash provided by (used in) financing activities	1,191,666	1,319,720
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(3,717)	1,026
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(271,732)	116,583
Cash and cash equivalents and restricted cash at beginning of period	542,484	216,993
Cash and cash equivalents and restricted cash at end of period	$ 270,752	$ 333,576